DE60022047D1 - Antivirale therapie - Google Patents

Antivirale therapie

Info

Publication number
DE60022047D1
DE60022047D1 DE60022047T DE60022047T DE60022047D1 DE 60022047 D1 DE60022047 D1 DE 60022047D1 DE 60022047 T DE60022047 T DE 60022047T DE 60022047 T DE60022047 T DE 60022047T DE 60022047 D1 DE60022047 D1 DE 60022047D1
Authority
DE
Germany
Prior art keywords
antiviral therapy
antiviral
hydrate
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60022047T
Other languages
English (en)
Other versions
DE60022047T2 (de
Inventor
Johannes Servatius Leon Nottet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNI MEDISCH CT UTRECHT UTRECHT
UNIVERSITEIT UTRECHT FACULTY O
Original Assignee
UNI MEDISCH CT UTRECHT UTRECHT
UNIVERSITEIT UTRECHT FACULTY O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202156A external-priority patent/EP1064940A1/de
Application filed by UNI MEDISCH CT UTRECHT UTRECHT, UNIVERSITEIT UTRECHT FACULTY O filed Critical UNI MEDISCH CT UTRECHT UTRECHT
Application granted granted Critical
Publication of DE60022047D1 publication Critical patent/DE60022047D1/de
Publication of DE60022047T2 publication Critical patent/DE60022047T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
DE60022047T 1999-07-02 2000-06-30 Antivirale therapie Expired - Fee Related DE60022047T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US14229799P 1999-07-02 1999-07-02
US142297P 1999-07-02
EP99202156 1999-07-02
EP99202156A EP1064940A1 (de) 1999-07-02 1999-07-02 Antivirale Therapie
EP00200991 2000-03-17
EP00200991 2000-03-17
PCT/NL2000/000460 WO2001001985A1 (en) 1999-07-02 2000-06-30 Antiviral therapy

Publications (2)

Publication Number Publication Date
DE60022047D1 true DE60022047D1 (de) 2005-09-22
DE60022047T2 DE60022047T2 (de) 2006-06-29

Family

ID=56290036

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022047T Expired - Fee Related DE60022047T2 (de) 1999-07-02 2000-06-30 Antivirale therapie

Country Status (7)

Country Link
EP (1) EP1194141B1 (de)
JP (1) JP2003503455A (de)
AT (1) ATE301997T1 (de)
AU (1) AU5856100A (de)
CA (1) CA2373879A1 (de)
DE (1) DE60022047T2 (de)
WO (1) WO2001001985A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148886A1 (de) 2001-10-04 2003-04-30 Avontec Gmbh Inhibition von STAT-1
EP1452605A1 (de) * 2003-02-27 2004-09-01 Universiteit Utrecht Holding B.V. Verfahren zum Nachweis von antiviraler Aktivität
EP3510172B1 (de) * 2016-09-07 2023-11-29 St Vincent's Hospital Sydney Limited Verfahren zum nachweis von hiv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973191A (en) * 1996-12-30 1999-10-26 Vanderbilt University Selective inhibitors of prostaglandin endoperoxide synthase-2
CA2313049A1 (en) * 1997-12-17 1999-06-24 Cornell Research Foundation, Inc. Cyclooxygenase-2 inhibition
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物

Also Published As

Publication number Publication date
ATE301997T1 (de) 2005-09-15
EP1194141A1 (de) 2002-04-10
DE60022047T2 (de) 2006-06-29
CA2373879A1 (en) 2001-01-11
WO2001001985A1 (en) 2001-01-11
JP2003503455A (ja) 2003-01-28
AU5856100A (en) 2001-01-22
EP1194141B1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
MXPA03005464A (es) Agentes antivirales.
GB9914486D0 (en) Medicaments
MY146279A (en) Compounds affecting glucokinase
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
SE0100568D0 (sv) Compounds
MXPA04012965A (es) Inhibidores virales.
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
SE0202462D0 (sv) Novel use
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
GB0112348D0 (en) Compounds
SE0202429D0 (sv) Novel Compounds
SE9901573D0 (sv) New compounds
DE60001586D1 (de) Diphenyl-piperidin derivate
SE0102440D0 (sv) New compound
GB0130677D0 (en) Medicaments and novel compounds
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
SE0100566D0 (sv) Compounds
SE0002476D0 (sv) New compounds
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee